Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Knowledge Is Power, Investing With Confidence in BAC, PFE, CVX and TWX

Marketwired February 19, 2013

Turn Timing Into Profits With INTC, PFE, NWSA and AFFY

Marketwired February 15, 2013

Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent News Announced for Crown Marketing

PR Newswire February 14, 2013

Market Movers, Money Makers -- Start Now With YHOO, JNJ, PFE and EBAY

Marketwired February 14, 2013

Were You in Early on GE, PFE, DELL and DIS

Marketwired February 13, 2013

Did You Miss PPG, VMED, PFE and AKAM

Marketwired February 8, 2013

Pain Therapeutics Reports 2012 Financial Results

Troy Schwensen February 6, 2013

Pfizer Inc. Issues Statement on ZoetisTM IPO

Business Wire February 1, 2013

Pfizer and Eli Lilly Rise on Fourth Quarter Earnings -- S&P 500 Index Hovers Near 5-Year Highs

Marketwired January 31, 2013

Special Situation Coming Soon, a Look Inside PFE, S, ESRX and UN

Marketwired January 31, 2013

Pfizer Wins RAPAMUNE® Patent Case in Delaware District Court

Business Wire January 31, 2013

Free Research Reports on ANAC, KERX, LXK and PFE Issued by the Bedford Report

Marketwired January 30, 2013

Key to Success, How to Profit: PBR, PFE, QCOM and RF

Marketwired January 29, 2013

Pfizer Reports Fourth-Quarter and Full-Year 2012 Results; Provides 2013 Financial Guidance

Business Wire January 29, 2013

Free Research Report on Ford Motor Co., Pfizer, Inc., Barclays Bank PLC, General Electric Co. and PowerShares QQQ Trust

PR Newswire January 28, 2013

Pfizer Receives FDA Approval For The Use Of Prevnar 13 In Vaccine-Naive Children And Adolescents Aged 6 Years Through 17 Years For The Prevention Of Invasive Pneumococcal Disease

Business Wire January 25, 2013

ChapStick® Sessions Applies a Spotlight on Musically Talented Lips

Business Wire January 24, 2013

Study Shows Higher Dose Of Toviaz® (fesoterodine fumarate) Offers Greater Efficacy In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder

Business Wire January 24, 2013

Pfizer Announces Top-Line Efficacy Results From A Phase 4 Study Of PRISTIQ® (desvenlafaxine) For The Treatment Of Major Depressive Disorder (MDD) In Adults

Business Wire January 24, 2013

The Reason It Trades, What's Moving AMD, COH, GE and PFE

Marketwired January 24, 2013